PCR128 Patient-Reported Symptoms Are the Sole Independent Predictor of the Societal Burden Associated With Inflammatory Bowel Disease: A Cross-Sectional Study

The societal burden of inflammatory bowel diseases (IBD) is not well documented in the literature, and further studies are needed to quantify these costs per disease state. This study aimed to estimate the societal burden and identify predictors of work productivity and activity impairment, productivity costs, and out-of-pocket costs related to IBD.